Developments in AI are leading to bioinformatics strengthening important advances in drug development and re-purposing. Although mathematical methods and computer programs, as such, are not patentable at the European Patent Office, the vast amount of genetic information which can now be gleaned by powerful nucleic acid sequencing techniques and developments in AI, means bioinformatics underpins many commercially important inventions for which protection can be obtained.
These inventions span the fields of personalised medicine, non-invasive foetal testing, innovations made possible by the latest sequencing techniques for interrogation of the human genome, and developments arising from growing knowledge of the genetic diversity of microbes.
HGF works with clients in fields ranging from major global corporations to start-up businesses, advising on, and patenting bioinformatics’ applications. The specialist attorneys keep pace with fast-moving developments in complex, multi-disciplinary fields, and expertly navigate and challenge patenting requirements as they impact on the areas of computer-implemented inventions and discoveries of the natural world.
Our dedicated team of individuals, with experience of commercial application of bioinformatics across life sciences, pharmaceuticals and electronics teams, provide cross-disciplinary IP strategies. This multidisciplinary approach combines members of the specialist microbiome team, attorneys with deep experience in computer software inventions, and HGF’s legal specialists with expertise in database rights and data protection.
HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …Event details
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
HGF is a gold sponsor at the BioCap Conference 2022. The conference will be held on Thursday 22 September at the Alderley Park Conference Centre. It connects life sciences businesses, …Event details
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …Read article
One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …Read article